Literature DB >> 5355342

Insulin responses to glucose: evidence for a two pool system in man.

D Porte, A A Pupo.   

Abstract

Four rapid glucose injections of 5 g each were administered to normal young adult subjects before, during, and after an infusion of glucose. After the first glucose pulse, insulin responses measured immunologically reached a peak between 3 and 5 min and rapidly returned to base line. A short glucose infusion of 300 mg/min decreased the rapid insulin response to a second glucose pulse (- 58%), but after a longer infusion (20 hr) the acute insulin response to a third pulse was restored to normal. Stopping the infusion was followed by return of glucose and insulin levels to prestudy base line within 1 hr, but a fourth glucose pulse was followed by a supernormal acute insulin response (+ 200%). Other observations during these studies showed that a short glucose infusion of either 100 mg/min or 300 mg/min produced a parallel rise in glucose and insulin, but continuation of the infusion for 20 hr was associated with a "paradoxical" fall in glucose and continued rise in insulin. These observations are considered incompatible with a simple linear model often used to describe the relation between plasma glucose and serum insulin. Instead, a two pool system-one for acute insulin release, and the other a time-dependent compartment for long term insulin responses-is suggested.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5355342      PMCID: PMC297488          DOI: 10.1172/JCI106197

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Capacity of the neurohypophysis to release vasopressin.

Authors:  H Sachs; L Share; J Osinchak; A Carpi
Journal:  Endocrinology       Date:  1967-10       Impact factor: 4.736

Review 2.  Catecholamines.

Authors:  R J Wurtman
Journal:  N Engl J Med       Date:  1965-09-23       Impact factor: 91.245

3.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

4.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus.

Authors:  E Cerasi; R Luft
Journal:  Acta Endocrinol (Copenh)       Date:  1967-06

5.  Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro.

Authors:  H G Coore; P J Randle
Journal:  Biochem J       Date:  1964-10       Impact factor: 3.857

6.  A new method for the measurement in vitro of pancreatic insulin secretion.

Authors:  W Malaisse; F Malaisse-Lagae; P H Wright
Journal:  Endocrinology       Date:  1967-01       Impact factor: 4.736

7.  The effect of epinephrine on immunoreactive insulin levels in man.

Authors:  D Porte; A L Graber; T Kuzuya; R H Williams
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

8.  An analogue computer model for the insulin response to glucose infusion.

Authors:  E Cerasi
Journal:  Acta Endocrinol (Copenh)       Date:  1967-05

9.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  A receptor mechanism for the inhibition of insulin release by epinephrine in man.

Authors:  D Porte
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

View more
  55 in total

1.  [Glucose-assimilation and dynamics of insulin secretion. Measurements after intra-abdominal operations (author's transl)].

Authors:  R Bittner; H G Beger; E Kraas; R Roscher
Journal:  Klin Wochenschr       Date:  1975-09-15

Review 2.  Can technological solutions for diabetes replace islet cell function?

Authors:  Justin M Gregory; Daniel J Moore
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

3.  Kalirin/Trio Rho GDP/GTP exchange factors regulate proinsulin and insulin secretion.

Authors:  Quinn Dufurrena; Nils Bäck; Richard E Mains; Louis Hodgson; Herbert Tanowitz; Prashant Mandela; Elizabeth Eipper; Regina Kuliawat
Journal:  J Mol Endocrinol       Date:  2018-11-01       Impact factor: 5.098

4.  Aged insulin granules display reduced microtubule-dependent mobility and are disposed within actin-positive multigranular bodies.

Authors:  Peter Hoboth; Andreas Müller; Anna Ivanova; Hassan Mziaut; Jaber Dehghany; Anke Sönmez; Martina Lachnit; Michael Meyer-Hermann; Yannis Kalaidzidis; Michele Solimena
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 5.  The artificial pancreas: is it important to understand how the β cell controls blood glucose?

Authors:  Garry M Steil; Gerold M Grodsky
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

6.  Contributions of fat and protein to the incretin effect of a mixed meal.

Authors:  Guillaume Carrel; Léonie Egli; Christel Tran; Philippe Schneiter; Vittorio Giusti; David D'Alessio; Luc Tappy
Journal:  Am J Clin Nutr       Date:  2011-08-17       Impact factor: 7.045

7.  Calcium antagonists and hormone release. IV. The role of calcium in glucose-stimulated early phase insulin release in vivo.

Authors:  L De Marinis; G Merlini; O Makhoul; A Barbarino
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

Review 8.  Diabetes mellitus: current concepts of the hormonal and metabolic defects.

Authors:  G Steiner
Journal:  Can Med Assoc J       Date:  1972-09-23       Impact factor: 8.262

9.  I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects.

Authors:  R Prando; R Cordera; A De Micheli; M Maiello; P Odetti; G Viviani; L Corsi; L Adezati
Journal:  Acta Diabetol Lat       Date:  1978 Sep-Dec

10.  Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

Authors:  R A DeFronzo; J D Tobin; J W Rowe; R Andres
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.